Cefuroxime MIP

Medicinal product

(Invented) name

Cefuroxime MIP

Active substance (s)

Cefuroksimas

Strength

1500 mg

Pharmaceutical form

milteliai injekciniam ar infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01DC02, Cefuroxime

Marketing authorisation holder

MIP Pharma GmbH, Vokietija

Date of authorisation

2013-02-08

Date of renewal

2022-05-18

Documents

3197 Cefuroxime MIP PCS PL 2023 05 22.docx

3197 Pakuotės lapelis 2023 05 22.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NO/H/0218/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Flakone yra:	1 vnt.
Cefuroksimas	1500 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
46852	60662	1060662	flakonas	N1		Receptinis	LT/1/13/3197/004	Netiekiama	-	-	No	-	-
55163	69196	1069196	flakonas	N5		Receptinis	LT/1/13/3197/005	Netiekiama	-	-	No	-	-
55164	69197	1069197	flakonas	N10		Receptinis	LT/1/13/3197/006	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-05-18	Perregistruotas
2013-02-08	Registruotas